SGLT2i and CV outcomes for patients with CV risk disease

Document ID: PC-AE-101739

02/06/2023

Author: Boehringer Ingelheim


SGLT2i and CV outcomes for patients with CV risk disease 

123,000
Views

100k 340

Related content

 
PC-AE-101739
Production date: June 2023